Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health Committee Hearings To Focus On HHS Importation Report

This article was originally published in The Pink Sheet Daily

Executive Summary

The committee will also hold hearings on the Dorgan/Snowe importation bill by the end of April. The legislation, which differs from legislation introduced by the senators last year, is backed by Finance Committee Chairman Grassley.

You may also be interested in...



FDA Warns Of Drug Name Confusion Abroad

The agency lists 120 U.S. brand names that are used for different active ingredients outside the U.S.

FDA Warns Of Drug Name Confusion Abroad

The agency lists 120 U.S. brand names that are used for different active ingredients outside the U.S.

Rx Importation Safer Than Current System, Former FDAer Kessler Says

Unregulated drug importation jeopardizes public health, former FDA Commissioner Kessler tells Senate Health Committee hearing, but regulated importation as proposed in bill by Sens. Dorgan and Snowe would provide "reasonable assurance that the drugs are safe and effective."

Related Content

Topics

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel